Ropivacaine – SLS 2 mg/ml
1.Therapeutic indications:
Ropivacaine SLS 2 mg/ml is indicated for acute pain management in:
– Adults and adolescents over 12 years of age (postoperative pain management)
– Infants from 1 year and children aged 12 years or less (pre- and postoperative pain management)
– In neonates, infants and children aged 12 years or less (pre- and postoperative pain management)
2. Dosage:
Adults and adolescents over 12 years of age:
Method of administration: perineural and epidural administration by infusion
Conc.
mg/ml |
Volume
ml |
Dose
mg |
|
ACUTE PAIN MANAGEMNT | |||
Lumbar Epidural Administration | |||
Continuous infusion labor pain | 2.0 | 6 – 10 ml/h | 12 – 20 mg/h |
Postoperative pain management | 2.0 | 6 – 14 ml/h | 12 – 28 mg/h |
Thoracic Epidural Administration | |||
Continuous infusion (postoperative pain management) | 2.0 | 6 – 14 ml/h | 12 – 28 mg/h |